NCT01241110

To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment

Phase 4 Study of Azitromicin in the Treatment of PID

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Guilan University of Medical Sciences · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

Objective: To compare two oral treatments: Ofloxacin + Metronidazole, and Azitromycin +Metronidazole in outpatients with Pelvic Inflammatory Disease. Materials and Methods: Two hundred patients divided to two groups( A , B). Group A (treated by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy

Detailed description

Two hundred patients divided to two groups( A , B). Group A (treated by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy

Conditions

• Pelvic Inflammatory Disease

Interventions

Type	Name	Description
DRUG	Ofloxacin group A, Azitromycin group B	Group A (treated by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy.
DRUG	azitromycin	azitromicin vs ofluxacin

Timeline

• Start date: 2010-01-01
• Primary completion: 2010-08-01
• Completion: 2010-09-01
• First posted: 2010-11-16
• Last updated: 2010-11-16

Locations

1 site across 1 country: Iran